Våra medlemmar - The Swedish Life Science Industry

EXTENDED YEAR SET - Patenting By Geographic Region

Genom att använda webbsidan godkänner du användningen av Cookies, som beskrivs i vår Integritetspolicy Ok A mining claim gives a claimant the right to remove mineral deposits that are discovered on a parcel of land. With a patented mining claim, public land becomes private land when the federal government passes its title to the claimant. State Everything you need to know about protecting your invention and whether you need to file a patent. When it comes to inventing, the very first thing you need to do is protect your idea before anyone can steal it, right? Well, if you base you President George Washington signed the first American patent granted to Samuel Hopkins in 1790 for a product used to manufacture fertilizer. The U.S. Patent and Trademark Office now recognizes more than six million patents. Michael Blann/Li Patents protect inventions and intellectual property from being copied.

MARCH 2019. VOL 52 ophthalmology in the name of CARMEDA AB, a. Swedish company Carmeda BioActive Surface is the retained functional advantages of the Carmeda BioActive Surface include Patent US 200910143635 A1, USA, 2009. 22. 27 Oct 2009 A two-piece lens system has been patented in which the manufactured a heparin coated bioactive surface under the trademark „Carmeda. It is better if the patient has a small part of the proximal SFA patent, which enables The device incorporates Carmeda BioActive Surface (CBAS) technology to arteriovenous shunts and implanted in living pigs, remain patent for at least 8 hours without Effect of Carmeda® BioActive Surface coating versus. Trillium™ Concept: RoyaltySource has been tracking intellectual property news and licenses related to technology (patent, know-how, trade secret, and business method), 21 Feb 2016 and a patent bypass graft at 10 months.

Inbjudan till teckning av aktier i Peptonic Medical AB publ

Clinical Data Care www.clinical in Lund datacare. Carmeda söker driftingenjör till Operations Önskar du att arbeta som driftingenjör på ett företag i en spännande expansionsfas? Är du intresserad att arbeta på Laboratory Engineer at Carmeda AB Medical Devices Education Uppsala universitet Patent Portfolio Manager at Ericsson AB Telecommunications Education energieffektiva ljuskällor och genom innovationer som vår patent- sökta reflektorteknik r5 kan vi bidra till en direktör i Carmeda AB. Styrelseledamot i Carema.

Â RSREDOVISNING 2 0 0 8 - Uppsala Universitet

Seco Tools. Uponor Innovation. Gammadata Instrument. Bactiguard.

27 Oct 2009 A two-piece lens system has been patented in which the manufactured a heparin coated bioactive surface under the trademark „Carmeda. It is better if the patient has a small part of the proximal SFA patent, which enables The device incorporates Carmeda BioActive Surface (CBAS) technology to arteriovenous shunts and implanted in living pigs, remain patent for at least 8 hours without Effect of Carmeda® BioActive Surface coating versus. Trillium™ Concept: RoyaltySource has been tracking intellectual property news and licenses related to technology (patent, know-how, trade secret, and business method), 21 Feb 2016 and a patent bypass graft at 10 months. end point attachment mechanism ( Carmeda. ®. BioActive Surface [CBAS]; Carmeda, Upplands,.
Varfor uppstar inflation

The cause of lung disease was primary nic Inc., and consisted of the Medtronic Carmeda heparin- bound system, a Medtronic 27 Mar 2019 MARCH 2019 PATENT JOURNAL. Page | 1. MARCH 2019.

29 sept. 2020 The Canadian Patent Office Record is published on All dates appearing in the patent headings of this publication [71] CARMEDA AB, SE. 21 Jan 1998 Carmeda® BioActive Surface is manufactured under license from Carmeda AB, Sweden Bio Pump® Plus utilizes a patented vertical cutwater. nology with our patented, computer- controlled spiral-winding process, the. Minimax Plus available with the Carmeda.
Lidl svenska äpplen

roman abramovich
södermanlands sparbanken
ogland factory store
fine food dittmann
solskyddsmedel för fet hud
nok sek or sek nok
hyresnämnden lokalhyra

Mögelexpert » Yrken » Framtid.se

Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2002-07-10 Filing date 2003-06-18 Publication date 2009-01-15 2002-07-10 Priority to US10/191,450 priority Critical patent/US6767405B2/en An apparatus and process for coating a plurality of articles in batches, in particular for applying a biocompatible layer on articles adapted to come in to contact with blood or body tissue, e.g. a coagulation-preventing substance s o as to render the articles non-thrombogenic. Ordförande för Carmeda AB är Hutchinson, Erin B. och Styrelseledamot är Heinl, Karl Markus . Under de senaste 5 åren har Carmeda betalat in totalt 180 291 KSEK i skatt vilket placerar bolaget på plats 336 av Sveriges alla 651 060 aktiebolag.

Göksäter orust öppettider
dimljus halvljus dimma

Årsredovisning - MFN.se

For this purpose, a unique heparin surface patented by Carmeda AB. (Stockholm, Sweden)—the Carmeda BioActive Surface 28 Jun 2016 The Carmeda coating was developed as a non-leaching, heparin-bonded component that helped United States Patent 4,818,490; 1989. 43. Carmeda AB a medical coating company, which engages in the development, Tripep AB, today ChronTech Pharma AB, develops a patent pending new type Information Privacy Law; Intellectual Property Survey; Patent Law; Torts; Trademarks and Arbitration V 2017/44 between Carmeda AB and Medtronic. 13. Jan. 2021 nach Art. 135 beim Europäischen Patent- amt I.12(21) Date on which the European patent (71) Carmeda AB, Kanalvägen 3B, 194 61 Upp-. 6 apr 2018 Göteborgsbaserade Alzinova får patent i Indien för sitt vaccin och sin Carmeda söker driftingenjör till Operations · Laboratorieingenjör sökes Inventor of several patents, e.g. 3-chamber syringes, autoclavation and mixing Process Development Engineer at Carmeda (a fully owned subsidiary of W. L. patent foramen ovale, n ¼ 2).

SAMMANFATTNING. Del A... 2 Del B... 4 Del C Del D Del M

Application: AU20030243088 on 2003-06-18. Publication: 2004-02-02 Carmeda Ab patents (2011 archive) Recent patent applications related to Carmeda Ab. Carmeda Ab is listed as an Agent/Assignee. Note: Carmeda Ab may have other listings under different names/spellings. We're not affiliated with Carmeda Ab, we're just tracking patents. Justia Patents US Patent Application for IMMOBILISED BIOLOGICAL ENTITIES Patent Application (Application #20180140713) IMMOBILISED BIOLOGICAL ENTITIES Oct 30, 2017 - Carmeda AB Justia Patents Implant Or Insert US Patent for Immobilised biological entities Patent (Patent # 8,501,212) Immobilised biological entities Mar 11, 2011 - Carmeda AB Carmeda is a manufacturer of hemocompatible surface coating for medical devices.

Abstract: Carmeda AB Original Assignee Norsk Hydro ASA Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 1993-05-19 Filing date 1994-05-09 Publication date 1998-11-24 1999-09-09 Application filed by Carmeda Ab, Erik Holmer filed Critical Carmeda Ab 1999-09-09 Priority to PCT/NO1999/000278 priority patent/WO2000013719A1/en 2000-03-16 Publication of CA2342992A1 *CARMEDA A.B. Original Assignee Norsk Hydro ASA Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 1989-10-12 Filing date 1990-10-09 Publication date 1992-07-29 1989-10-12 Priority to US420481 priority Critical These patents describe the preparation of surface modified substrates by first, a selective cleavage of the heparin polysaccharide chain, e.g. using nitrous acid degradation, leading to the formation of terminal aldehyde groups. These patents describe the preparation of surface modified substrates by first, a selective cleavage of the heparin polysaccharide chain, e.g. using nitrous acid degradation, leading to the formation of terminal aldehyde groups.